PRELUDE CAPITAL MANAGEMENT, LLC - CYCLERION THERAPEUTICS INC ownership

CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 70 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CYCLERION THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$80,000
+15.9%
92,541
-26.7%
0.00%
+50.0%
Q2 2022$69,000
-37.8%
126,192
+25.9%
0.00%
-33.3%
Q1 2022$111,000
-16.5%
100,255
+29.2%
0.00%0.0%
Q4 2021$133,000
+1.5%
77,583
+82.4%
0.00%0.0%
Q3 2021$131,000
-32.8%
42,542
-15.1%
0.00%
-50.0%
Q2 2021$195,000
+1525.0%
50,104
+4910.4%
0.01%
+500.0%
Q3 2019$12,0001,0000.00%
Other shareholders
CYCLERION THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Slate Path Capital LP 7,157,601$6,156,0000.40%
MFN Partners Management, LP 3,389,215$2,915,0000.13%
Diametric Capital, LP 243,711$210,0000.11%
Artal Group S.A. 2,779,122$2,391,0000.10%
Intrinsic Value Partners, LLC 48,315$42,0000.06%
TRUSTCORE FINANCIAL SERVICES, LLC 292,645$252,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 115,000$99,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 92,541$80,0000.00%
COLONY GROUP LLC 102,884$88,0000.00%
ACADIAN ASSET MANAGEMENT LLC 231,952$198,0000.00%
View complete list of CYCLERION THERAPEUTICS INC shareholders